Possible biomarker and therapeutic target for melanoma identified
March 18th, 2011 - 4:50 pm ICT by ANIWashington, March 18 (ANI): Scientists have identified a potential new biomarker and therapeutic target for melanoma.
The novel cell screening method used in the study also clarifies the process behind tumor metastasis and may allow the identification of biomarkers for other aggressive cancers.
Researchers at Boston University School of Medicine (BUSM), in collaboration with Johns Hopkins University investigated the process through which melanoma cells communicate with blood vessel cells and promote the formation of tube-like conduits that may allow for tumor metastasis. With the combined expertise of the biologists and biomedical engineers they used microfluidics technology to identify molecules that were essential to this communication process.
They found that the molecule Neuropilin-2 played a large role in the process and that silencing it inhibited cancer cell growth.
“We found that Neuropilin is an important mediator of melanoma cell and blood vessel cell interactions,” said Rhoda Alani, BUSM professor and Chair of Dermatology.
“We can now investigate this molecule as a potential biomarker and melanoma treatment target. We can also use the unique methodology developed in these studies to evaluate cellular crosstalk between other tumor cell types and vessel cells. Such studies are likely to provide important insights into the metastatic process for other cancers.”
According to the researchers the cell-to-cell communication process necessary for metastasis of tumors has garnered much attention recently but detailed knowledge of its underlying molecular mechanisms is lacking. These findings clarify this process in melanoma tumors and support the use of the team’s methods to discover novel factors controlling cell communication for a variety of malignances
The findings now appear online in Cancer Research. (ANI)
- Small molecules 'could block cell proliferation in cancerous human tumor' - Apr 14, 2011
- Molecules that help propel cancer metastasis identified - Apr 08, 2011
- Melanoma spreads to lungs using body's immune system - Oct 08, 2010
- Scientists identify molecules that help propel cancer metastasis - Apr 09, 2011
- Biomarker-based blood test can predict metastasis risk in melanoma - Apr 16, 2011
- Major breakthrough could lead to new treatments for melanoma - Dec 23, 2010
- New method reveals how cancerous tumors evolve and spread - Mar 14, 2011
- Personalized cancer medicine now a step closer to reality - Apr 16, 2011
- New way to halt expansion of breast cancer stem cells discovered - Nov 24, 2010
- Nanotechnology may lead to new liver cancer treatment - Feb 23, 2011
- Melanoma-initiating cell identified - Jul 01, 2010
- Key enzyme in melanoma cell development found - Jun 18, 2010
- Zebrafish offers skin cancer clues - Apr 06, 2011
- Microsponges from seaweed may help diagnose diseases quickly - Feb 10, 2011
- Now, a disposable device to identify aggressive breast cancers - Sep 29, 2010
Tags: biomarker, biomarkers, biomedical engineers, blood vessel cells, boston university school, boston university school of medicine, busm, cancer cell growth, cancer research, cell communication, cell interactions, communication process, crosstalk, johns hopkins university, melanoma cells, molecular mechanisms, screening method, therapeutic target, tumor cell, tumor metastasis